The Potential Clinical Application of Comprehensive Genomic Profiling in Targeted Therapy and Immunotherapy of Lung Cancer

被引:0
作者
Chen, M. [1 ]
Hu, J. [2 ,7 ]
Wang, L. [3 ]
Li, G. [4 ]
Liu, C. [5 ]
Wang, M. [6 ]
Dai, L. [1 ]
Wang, W. [7 ]
Chirn, G. [7 ]
Mu, S. [7 ]
Chen, L. [7 ]
Hu, J. [2 ,7 ]
Yao, M. [7 ]
Wang, K. [7 ]
机构
[1] Guangxi Med Univ, Affiliated Hosp 1, Guangxi, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Hangzhou, Zhejiang, Peoples R China
[3] Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China
[4] Kunming Med Univ, Affiliated Hosp 3, Kunming, Yunnan, Peoples R China
[5] Dalian Med Univ, Hosp 2, Dalian, Peoples R China
[6] Zhejiang Univ Int Hosp, Shulan Hangzhou Hosp, Hangzhou, Zhejiang, Peoples R China
[7] Origimed, Shanghai, Peoples R China
关键词
TMB; PD-1 blockade immunotherapy; MSI;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1.07-038
引用
收藏
页码:S2009 / S2009
页数:1
相关论文
empty
未找到相关数据